EFNB2 and breast carcinoma: Idarubicin, a chemotherapy medication that’s currently used to treat breast cancer, was identified via virtual screening to potentially bind to the EphB2-ephrinB2 complex, where the expression of the complex is associated with cancer cells as shown in Fig. 6.